Filing Details

Accession Number:
0001104659-19-029779
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 17:14:00
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 17:14:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705850 E Joseph Gilliam C/O Glaukos Corporation,
229 Avenida Fabricante
San Clemente CA 92672
Cfo, Svp Corporate Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-13 103 $41.69 47,166 No 4 M Direct
Common Stock Disposition 2019-05-13 103 $68.50 47,063 No 4 S Direct
Common Stock Acquisiton 2019-05-13 2,500 $30.92 49,563 No 4 M Direct
Common Stock Disposition 2019-05-13 2,500 $65.00 47,063 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2019-05-13 103 $0.00 103 $41.69
Common Stock Stock Options (Right to Buy) Disposition 2019-05-13 2,500 $0.00 2,500 $30.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
187,990 2027-05-05 No 4 M Direct
53,045 2028-03-14 No 4 M Direct
Footnotes
  1. Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
  3. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.